Translational Stem Cell Therapy Foundation Inc
Nonprofit profile at a glance
- EIN
- 274358901
- IRS 990-EZ coverage
- 2014–2022
- Forms available
- Form 990 2021, Form 990-EZ 2022
- Location
- Gilbert, AZ, USA
- Rating confidence
- Limited
- Sector
- Alliance/Advocacy Organizations
Reported finances
- Revenue
- $0
- Expenses
- $512,606
- Assets
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2022. Amounts in USD.
Leadership & pay
2 people listed
People named in this filing
- LORRI LAWSON (Director/Presid)
- LOUIS SARATOGA (Secretary)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2022. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The Foundation will operate as a public charity to raise awareness of the medical benefits of stem cell research, foster increased donations by the public of cord blood and perform research on cord blood stem cells. The Foundation will provide education, research and training to inform and assist the public, physicians, hospitals and other organizations about the benefits of cord blood storage and the use of cord blood stem cells in the treatment of various genetic disorders.
What it reported doing in 2022
Provided educational and financial support to promote cord blood banking awareness provided financial assistance for cord blood processing costs.
Operating model
- Revenue model
- Cannot be determined from the filing. The filing does not provide enough consistent revenue detail to tell how this nonprofit funds its work.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: 37
- Transparency & Controls: 74
- Sustainability: 2
- Growth: 100
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: 97.7%; rating input score 98
Transparency & Controls
- Consistency checks: 90%; rating input score 90; 2nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: 0; rating input score 2; 2nd percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 12.2%; rating input score 10; 10th percentile among comparable filings
Growth
- Program expense growth: 14.4% per year; rating input score 100; 78th percentile among comparable filings
- Revenue growth: 3.5% per year; rating input score 100; 69th percentile among comparable filings
- Asset growth: 9% per year; rating input score 100; 69th percentile among comparable filings
Details
- Where the money goes: 97.7% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $501K in reported program spending
- Leadership: top reported pay $0 · 2 people listed
- Consistency: 5 of 5 current checks pass
- Schedules: 3 filed schedules
- Filing history: 2 filing years from 2014 to 2022
- Contacts: How to reach this organization
- Money network: 2 filed money-flow records
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Sustainability: Total-asset coverage ratio scored 2/100.
- High — Sustainability: Officer compensation ratio scored 10/100.